MRT Inc.

MRT Inc.

TTSE:6034
488.00
JPY
0.00
(0.00%)
17.66EPS
41.66P/E
3.40BMarket Cap
Feb 12Next Earn
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
204.71
217.76
209.85
220.46
285.99
394.88
461.43
803.85
1,567.73
571.27
761.91
744.89
734.87
Basic EPS, GAAP
1.76
25.12
26
16.82
5.93
17.28
23.74
139.3
387.53
54.77
-56.55
9.91
14.88
Free Cash Flow per Basic Share
-18.18
51.54
18.53
1.48
14.03
5.33
33.13
-72.96
795
-30.01
78.78
60.52
55.77
Dividend per Share
- -
- -
- -
- -
- -
- -
- -
- -
- -
17.42
0.03
0.03
0.01
Book Value per Share
51.3
156.46
239.18
274.36
277.15
262.88
272.86
398.71
787.85
840.97
789.77
839.49
832.28
Tangible Book Value per Share
41.04
148.77
230.52
216.34
179.41
181.68
178.76
324.56
639.57
710.4
682.33
729.67
723.58
Basic Weighted Avg Shares
4
4
5
5
5
6
6
6
6
9
5
6
6
Sales/Revenue/Turnover
728
832
1,005
1,155
1,502
2,232
2,562
4,469
8,738
5,407
4,166
4,191
4,102
Operating Margin (%)
7.62
20.87
20.33
13.49
4.32
2.35
10.32
28.35
34.07
15.42
-2.88
2.29
3.34
Depreciation Expense
28
20
21
49
58
44
154
180
185
229
259
247
245
Net Income, GAAP
6
96
124
88
31
98
132
774
2,160
518
-309
56
83
Effective Tax Rate (%)
52.98
38.29
35.8
37.37
55.55
36.62
33.66
35.94
25.68
37
- -
53.92
38.42
Profit Margin (%)
0.86
11.54
12.39
7.63
2.07
4.38
5.14
17.33
24.72
9.59
-7.42
1.33
2.03
Working Capital
242
681
969
804
590
1,378
1,040
1,587
3,229
3,544
2,047
1,687
1,511
LT Debt
3
1
- -
19
7
787
715
419
238
128
562
361
319
Total Equity
238
726
1,294
1,487
1,502
1,496
1,557
2,293
4,485
4,717
4,628
4,647
4,569
Return on Invested Capital (%)
- -
20.93
12.37
6.79
1.85
1.6
6.63
24.72
45.05
9.22
- -
0.81
1.66
Return on Capital (%)
- -
19.77
12.48
6.35
2.38
4.8
4.69
25.08
49.87
9.35
- -
1.27
1.51
Return on Common Equity (%)
- -
19.91
12.63
6.56
2.15
6.63
8.77
41.44
65.32
11.56
-6.8
1.22
1.87

Capital Structure

JPY

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
ST Debt
194
192
193
LT Borrowings
117
104
48
LT Finance Leases
287
257
271
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
6
6
5
Market Capitalization
3,883
3,453
3,404

Working Capital

JPY

•

in mil. unless spec.
Sep'25
Dec'25
Mar'26
Total Current Assets
3,081
2,893
2,576
Cash, Cash Equivalents & STI
2,389
2,232
1,801
Accounts Receivable, Net
453
450
532
Inventories
48
41
31
Total Current Liabilities
1,091
1,206
1,066
Payables & Accruals
- -
- -
- -
ST Debt
194
192
193
Deferred Revenue
- -
- -
- -

Growth Rates

JPY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
24.44%
29.31%
0.41%
Free Cash Flow
-73.68%
-378.37%
-20.93%
Net Income, GAAP
49.73%
62.56%
-118.04%
Sales/Revenue/Turnover
23.87%
21.89%
0.62%
Total Cash Common Dividend
- -
- -
-15.57%

Quarterly Revenue

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
937
1,283
933
1,012
4,166
2025
997
1,330
938
927
4,191
2026
907
- -
- -
- -
- -

Quarterly Earnings Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
-12.28
18.18
-17.8
-44.71
-56.55
2025
-18.72
32
0.16
-3.7
9.91
2026
-14.45
- -
- -
- -
- -

Quarterly Dividends Per Share

JPY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.03
- -
- -
- -
0.03
2025
0.02
- -
- -
0.01
0.03
2026
- -
- -
- -
- -
- -

Company Description

CEO
Masaaki Arai
Full Time Employees
307
Sector
Commercial services
Industry
Miscellaneous commercial services
Address
1-18-2 Jinnan Tokyo TY Japan 150-0041
IPO Date
Dec 26, 2014
Business
MRT Inc. (6034.T) operates a medical information platform primarily focused on healthcare human resources services and related digital solutions in Japan. The company provides temporary and part-time physician referral services through dedicated websites; career change support and staffing for nurses, pharmacists, clinical laboratory technicians, clinical engineers, and radiologists; groupware supporting medical office operations; remote healthcare and online health consultation services via platforms like Door.; dental clinic information platforms such as Shica.com; physician-led marketing and product development; publishing and pharmaceutical promotion support; registration and reception center operations; well-being services; research and development of analytical methods for biological samples including microorganisms, blood, proteins, and genes; and manufacture and sale of medical examination equipment and analytical instruments. Founded on January 26, 2000, and headquartered at 3F Frame Jinnan-zaka, 1-18-2 Jinnan, Shibuya-ku, Tokyo, Japan, MRT maintains additional offices in Dogenzaka (Tokyo), Sapporo, Nagoya, Osaka, and Fukuoka to serve nationwide operations targeting physicians, co-medical staff, medical institutions, municipal governments, and pharmaceutical companies. In November 2024, MRT entered a capital and business alliance with ITOCHU Corporation, receiving approximately ¥215 million in funding to enhance pharmaceutical marketing support, healthcare DX initiatives, and expansion of its physician referral platform enrolling over 350,000 professionals; the company also announced equity buybacks of 130,000 shares in November 2025 for ¥110 million and in January 2025 for ¥120 million.